Texas Ibogaine Research Advances, Signaling Potential Multi-State Coordination

Texas announced significant progress on its $50 million ibogaine research program, focusing on in-state medical teams after external proposals fell short. This critical development coincides with Mississippi's new HB314, which mandates its research consortium to coordinate with and use the same drug developer as a lead consortium in another state, effectively tethering it to the Texas-anchored network.